New England Securities’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q4 | $642K | Buy |
10,338
+411
| +4% | +$25.5K | 0.23% | 116 |
|
|
2014
Q3 | $516K | Sell |
9,927
-1,203
| -11% | -$62.5K | 0.18% | 137 |
|
|
2014
Q2 | $571K | Buy |
11,130
+1,710
| +18% | +$87.7K | 0.2% | 135 |
|
|
2014
Q1 | $447K | Buy |
9,420
+174
| +2% | +$8.26K | 0.17% | 146 |
|
|
2013
Q4 | $401K | Buy |
9,246
+1,203
| +15% | +$52.2K | 0.17% | 161 |
|
|
2013
Q3 | $346K | Sell |
8,043
-33
| -0.4% | -$1.42K | 0.17% | 150 |
|
|
2013
Q2 | $281K | Buy |
+8,076
| New | +$281K | 0.19% | 127 |
|